tiprankstipranks
Trending News
More News >

Ideaya Biosciences announces FDA clearance for IDE849

Ideaya Biosciences (IDYA) announced the clearance of an investigational new drug application with the FDA for the initiation of a Phase 1 clinical trial to evaluate IDE849, a potential first-in-class delta-like ligand 3-targeting Topo-I-payload antibody drug conjugate program, in solid tumors.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1